Omnipod 5 gets FDA approval

Insulin pump manufacturer Insulet has announced their new Omnipod 5 device has at last received regulatory approval from the American Food and Drug Administration (FDA) after months of delay caused by the covid pandemic. The approval means that the Omnipod 5 will be used with Dexcom’s G6 continuous glucose monitor providing their first closed-loop insulin delivery system via a tubeless pump. The system detects changes in blood glucose levels and automatically adjusts patients’ insulin doses. The device provides three days of continuous insulin dosing in a disposable, wearable patch pump. Wall Street investors have labelled Omnipod 5 as the year’s most exciting new medical device as the market for wearable devices such as insulin pumps and continuous glucose monitors takes off.

Desang Diabetes Magazine is our free-to-receive digital journal (see below). We cover diabetes news, diabetes management equipment (diabetes ‘kit’ such as insulin pumps and continuous glucose monitoring equipment) and news about food suitable for a diabetic diet including a regular Making Carbs Count column. We just need your email address to subscribe you (it really is free, and you can easily unsubscribe should you wish to).
Sign me up!
Open publication
Buy a Desang kitbag

See our range of kitbags